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Abstract
The presence of uniformly small collagen fibrils in tendon repair is believed to play a major role in suboptimal tendon
healing. Collagen V is significantly elevated in healing tendons and plays an important role in fibrillogenesis. The objective
of this study was to investigate the effect of a particular chain of collagen V on the fibrillogenesis of Sprague-Dawley rat
tenocytes, as well as the efficacy of Col V siRNA engineered tenocytes for tendon tissue engineering. RNA interference gene
therapy and a scaffold free tissue engineered tendon model were employed. The results showed that scaffold free tissue
engineered tendon had tissue-specific tendon structure. Down regulation of collagen V a1o ra2 chains by siRNAs (Col5a1
siRNA, Col5a2 siRNA) had different effects on collagen I and decorin gene expressions. Col5a1 siRNA treated tenocytes had
smaller collagen fibrils with abnormal morphology; while those Col5a2 siRNA treated tenocytes had the same morphology
as normal tenocytes. Furthermore, it was found that tendons formed by coculture of Col5a1 siRNA treated tenocytes with
normal tenocytes at a proper ratio had larger collagen fibrils and relative normal contour. Conclusively, it was demonstrated
that Col V siRNA engineered tenocytes improved tendon tissue regeneration. And an optimal level of collagen V is vital in
regulating collagen fibrillogenesis. This may provide a basis for future development of novel cellular- and molecular biology-
based therapeutics for tendon diseases.
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Introduction
Tendons and ligaments are frequently targets of injury from
trauma in sports and aging [1,2]. It is well known that tendons and
ligaments do not heal through a regenerative process; Instead,
their healing occurs via the formation of a fibrotic scar [3–5]. In
the healing tendon, a uniform distribution of small diameter col-
lagen fibrils has been found with poorer mechanical properties
than native tissue and shows no improvement of mechanical
properties with time[6]. Previous studies have shown that the
diameter of collagen fibrils in soft tissues has a positive correlation
with collagen mechanical strength [7,8]. So, the generation of
larger diameter fibrils is believed to promote biomechanical pro-
perties of healing tendons.
Fibril-forming collagens in most connective tissues include
collagen types I, III, and V. Collagen V is a quantitatively minor
component of the tissues such as dermis, tendon/ligament and
bone. Unlike cornea, where collagen V represents 20 to 25% of
the total collagen and such high percentage contributes to their
transparence [9], in most above tissues the relative concentration
of collagen V is significantly lower, only 1 to 3%. However, col-
lagen V has a key role in the regulation of initial fibril assembly.
Type V and Type I collagen are co-assembled into heterotypic
fibrils. The entire triple-helical domain of the type V collagen
molecules is buried within the fibril and type I collagen molecules
are present along the fibril surface [10,11], and the retained NH2-
terminal domains of the type V collagen are exposed at the
surface, extending outward through the gap zones. At the early
stage of assembly, immature fibril segments is regulated by the
NH2-terminal domain of type V collagen [11]. These NH2-termi-
nal domains alter accretion of collagen molecules onto fibrils and
therefore lateral growth. A critical density of type V collagen would
favortheinitiationofnewfibrilsratherthanthecontinuedgrowthof
existing fibrils. Type V collagen molecules may contain a1 (V),
a2(V) and a3(V) chains [12,13]. There are several collagen V
isoforms that differ in chain composition, such as a1(V)2a2(V)
heterotrimer, a1(V)a2(V)a3(V) heterotrimer, a1(V)3 homotrimer
[14–16]. However, collagen fibrils in tendon and ligament are
heterotypic type I/V fibrils and a1(V)2a2(V) is the favored and
functional heterotrimer [16,17]. Ultrastructural immunolocaliza-
tion demonstrated that the homotrimer a1(V)3 was localized at the
surface of wide collagen I fibrils as thin filamentous structures and
did not regulate fibril assembly, whereas the heterotrimer a1(V)2
a2(V) was buried in the fibril interior and regulated collagen
fibrillogenesis [18]. Studies have indicated that the occurrence of a
uniform distribution of small diameter collagen fibrils [6], along
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after injury [19]. Several investigations have shown that type V
collagen plays a role in regulatingthe diameterof the typeI collagen
fibril during fibrillogenesis [10,11,20,21]. The collagen fibril
diameter was inversely proportional to type V/type I collagen
ratios [23], i.e. the higher concentration of type V, the smaller the
fibril diameter [19]. Although the involvement of collagen V in
tendon matrix organization is well established, the functional
significance of the particular chains of collagen V in tendon tissue
engineering is remained unknown.
At present, the models for investigating tendon biology include
cell and animal models [21,22]. Cell models are simple, however,
are not convenient for the subsequent investigation of collagen
fibril synthesis [22,23]. Animal models are powerful for detecting
collagen fibril synthesis, but contain more influencing factors than
in vitro study and ethical difficulties also present. Previous studies by
our group successfully utilized mesenchymal stem cell sheets assem-
bled with frozen tendon graft for tendon tissue engineering [24]. In
this study, a scaffold-free tissue engineered tendon was developed
with tenocyte sheets. This provides a simple and controllable 3-D
tissue engineering model, which mimics tissue in vivo and makes the
tendon biological study in vitro feasible.
The objective of this study was to investigate the effect of
particular chain of collagen V on the fibrillogenesis of tenocytes, as
well as the efficacy of Col V siRNA engineered tenocytes for ten-
don tissue engineering. RNA interference technology is an efficient
tool for silencing endogenous or exogenous genes by complemen-
tary binding to the target mRNA [25]. Since there are two collagen
Figure 1. Gene expression profiles of injured tendon at 1 week
after injury and normal tendon tissue (*P,0.05, **P,0.01,
***P,0.001 compared with normal tendon group, n=3).
doi:10.1371/journal.pone.0021154.g001
Figure 2. Morphology and biochemical properties of tissue engineered tendon. (A) Construction of in vitro tissue engineered tendon. (B)
Gene expression of tissue engineered tendon in contrast to normal Achilles tendon tissue. (C, D) Histological examination and Masson trichrome
staining of tissue engineered tendon (**P,0.01, ***P,0.001 compared with normal tendon group, n=3).
doi:10.1371/journal.pone.0021154.g002
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two chains of type V collagen synthesis separately in tissue
engineered tendon model as a logical approach to understanding
the role of type V collagen during the tendon healing process.
Results
Gene expression of injured and normal tendon tissue
To verify the expression of different chains of collagen V in the
injured tendon, real time PCR was used to detect their mRNA
expression 1 week after surgery and compare with that of normal
tendon tissue. The results showed that injured tendon had
significant higher expression levels of Col1a1, Col3a1, Col5a1
and Col5a2 than those in normal tendon tissue (Fig. 1, P ,0.05 or
P,0.01), whereas those of Col5a1 and Col5a2 were much higher,
so we choose these two for further study.
Morphology and biochemical properties of the in vitro
tissue engineered tendon
Rat Achilles tenocytes proliferated rapidly and formed coherent
cellular sheets within 2 weeks after attaining confluence in the
presence of ascorbic acid. After the sheets formed, they could be
detached from the culture substratum, so a tissue engineered
tendon with living cells and collagen matrix which had a relatively
compact structure was obtained (Fig.2A). Hematoxylin-eosin and
Masson trichrome staining of tissue engineered tendon revealed a
tissue-specific tendon structure: organized bundles of highly
crimped fibrils and cells oriented in parallel (Fig. 2C, D). And
the real time PCR results showed that the cultured cell sheet had
high level of collagen V expression (Fig. 2B).
Transfection of siRNA against collagen V efficiently
suppressed collagen V expression in rat Achilles tenocytes
We transfected two silencer pre-designed siRNA sequences
against different chains of collagen V into rat achilles tenocytes by
Lipofectamine 2000. As demonstrated by fluorescent microscopy,
uptake of the siRNAs by rat Achilles tendon was highly efficient.
The green fluorescent signal was observed as early as 1 h after
transfection and reached a maximum at 6 h and could still be seen
48 h after the application of oligonucleotides (Fig. 3A).
Forty-eight hours after transfection, real time PCR analysis
revealed siRNA196227 (Col5a1 siRNA) and siRNA s136862
(Col5a2 siRNA) led to remarkable suppression of Col5a1 and
Col5a2 expression respectively compared to the negative control
group (NC: scrambled siRNA). There was at least ,70%
knockdown of collagen V mRNA (Fig. 3B, P,0.05). The positive
control (PC: GAPDH siRNA) also had evident suppression of
GAPDH (data not shown). The positive control was used to verify
the methods of siRNA transfection. Taken together, we chose
siRNA 196227 and siRNA s136862 in the subsequent experi-
ments.
As shown in the collagen V immunofluorescence staining results
(fig. 3C, D), tendon cells had decreased fluorescence in response to
particular siRNA interference, which indicates down-regulation of
Col5a1 and Col5a2 at the protein level. The control group (cells
treated with transfection agent only) showed high level of
fluorescence indicating constitutively high levels of type V
procollagen a1 and a2 expression, while Col5a1 siRNA decreased
the expression level of Col5a1b y,36.6%, and Col5a2 siRNA
down-regulated the level of Col5a2b y,33.7%. Such findings
were consistent with the mRNA expression results. These data
Figure 3. Transfection of siRNA against collagen V strongly suppressed collagen V expression in rat Achilles tenocytes. (A)
Transfection efficiency of FAM-labeled scrambled siRNA delivery. (B) Gene expression at 48 h after transfection. In each case, negative control values
were set to 1.0 and the rest of the values normalized to it. The housekeeping gene b-actin was amplified as an internal control. The results are
expressed as mean 6SD. PC, positive control: GAPDH siRNA; NC, negative control: scrambled siRNA (*P,0.05, ***P,0.001 compared with negative
control group, n=3). (C, D) Representative immunostaining for Col5a1 and Col5a2 at 48 h after transfection. Control: Cells treated with transfection
agent only. The value represented the mean color density of each cell.
doi:10.1371/journal.pone.0021154.g003
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at the mRNA and protein levels by siRNA interference methods.
Effect of different chain of collagen V on cell proliferation
and apoptosis
The MTT assay for tendon cell viability revealed that both of
the siRNA treatments caused little difference between the groups
at day 1 after transfection. The reduction in OD570 was statistically
significant for cells treated with Col5a1 siRNA and Col5a2 siRNA
(Fig. 4A, P,0.05) at day 3. The mean 6 SD OD570 was
0.22960.0208 and 0.22160.018 for cultures treated with Col5a1
siRNA and Col5a2 siRNA, respectively. While the OD570value in
control cells was 0.27160.0216. These results clearly indicated
that down regulation of both chains of collagen V had a modest
negative influence on the viability of tendon cells.
In DAPI staining, the labeled DNA of viable cells was scattered
throughout the nuclei, and bright condensation of chromatin
revealed apoptotic cells. A few more apoptotic cells were found in
the Col5 siRNA group (Fig. 4B). These results indicate that the
lower growth rate of cells treated with COL5 siRNA may have
been caused by the increased apoptosis when the collagen V was
down-regulated (26).
Different chains of collagen V have different effects on
fibrillogenesis and collagen fibril diameter
The amount of collagen deposited in the tissue engineered
tendon was shown in Fig. 5A. The mean 6 SD of collagen depo-
sition was (35.167.3) % and (38.966.8) % of the value in control
cells for cultures treated with Col5a1 siRNA and Col5a2 siRNA,
respectively (P,0.05). There was less of a difference between the
two experimental groups. The results indicated that down-regu-
lated collagen V impaired collagen expression in Achilles tenocytes.
Transmission electron microscopy (TEM) results showed that
the in vitro tissue engineered tendon had organized collagen fibrils.
However, tissue engineered tendon treated with Col5a1 siRNA
had abnormal fibril ultrastructure, while the fibrils from tendon
treated with Col5a2 siRNA was similar to that of the control (data
not shown). Comparison of mean fibril diameters in different
treatment are shown in Fig. 5B. The relative mean diameters of a1
siRNA and a2 siRNA treatments were about (80.6610.06)% and
(87.3610.11)% of the control.
Different chains of collagen V have different effects on
matrix gene expression.
To clarify the molecular events after blocking collagen V
expression, we also assessed the expression of some important
collagen and decorin genes by real time PCR and compared their
proportions to collagen type I. The expression of Col1a1w a s
down regulated when either siRNA was added, especially
reduced by Col5a2s i R N At o,16.5% (Fig. 5C, P,0.01). Quan-
titive PCR analysis also showed both collagen type III and
decorin mRNA levels were decreased after dealing with Col5a1
siRNA or Col5a2 siRNA (Fig. 5D and F). These finding indicate
that the block of Col V may affected the synthesis of these
extracellular matrix.
In the Col5a1 siRNA treated group, the ratios of Col5a1/
Col1a1, Col3a1/ Col1a1 and decorin/Col1a1 were sharply de-
creased by 70.5%, 20.6% and 48.7%, respectively. In the Col5a2
Figure 4. Effect of down regulation of different chain of collagen V on cell proliferation, apoptosis and collagen synthesis. (A) Cell
proliferation treated with siRNA at 1 day or 3 days. (B) Apoptosis with DAPI staining at 3 days after transfection.
doi:10.1371/journal.pone.0021154.g004
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by 68.5%, whereas the ratios of Col5a1/Col1a1 and decorin/
Col1a1 were increased by 30.7% and 75.9%, respectively (Fig.5
G–I). These results indicated that Col5a1 siRNA and Col5a2
siRNA have different function in regulating matrix gene expres-
sion at the mRNA level, and may indirectly lead to different effects
on collagen synthesis and tendon repair.
Transmission electron microscopy analysis of tissue
engineered tendons formed by coculture of Col5a1 siRNA
treated tenocytes and normal tenocytes in different ratios.
Since tissue engineered tendons treated with Col5a1siRNA had
abnormal collagen fibrils, a possible explanation is that the cor-
responding chain of collagen type V is over-suppressed. So we
cocultured Col5a1 siRNA treated tenocytes and normal tenocytes
with ratios of 1:0, 1:0.5, 1:1, 1: 2, 1:3 and 0:1 (NC group). As
shown in Fig.6 (A–F) are their transmission electron microscopic
analysis and histogram of collagen fiber diameters of tissue
engineered tendons. Compared with collagen fibrils of the control
group, collagen fibrils of cocultured groups with a ratio of 1:0.5 or
1:1 had similar morphology and relative larger diameters with the
mean diameter (118.867.52)% and (109.865.78)% (Fig.6G) of the
control, respectively. While collagen fibrils of cocultured groups
with a ratio of 1:2 or 1:3 were (9466.56)% and (84.965.83)%
(Fig.6G) of the control group. Those results indicate that
regulating the quantity of collagen type V a1 to a proper level is
beneficial for the generation of larger diameters.
Discussion
The present study for the first time demonstrated the use of a
scaffold-free tissue engineered tendon model for investigating the
biological function of collagen V in tendon fibrillogenesis. We
found that the type V procollagen a1 and a2 chains had different
effects on regulating tendon matrix gene expression to some extent
and an optimal level of collagen type Va1 is vital in regulating
collagen fibrillogenesis. Col V siRNA engineered tenocytes im-
proved tendon tissue engineering. These findings present a good
example of in vitro tissue engineering model for tendon biology
investigation and may provide basis for future development of cell
or gene therapy for tendon repair.
The basic function of tendon is to transmit force from muscle to
bone, which makes limb and joint movement possible. Therefore
tendons must be capable of resisting high tensile forces with
limited elongation. Parry and his colleagues reported that the me-
chanical properties of tendons are related to the fibril diameter
distribution, large fibrils could withstand higher tensile forces [8].
Moreover, investigations have also showed that a greater fibril
diameter generates greater tensile strength and the relative smaller
fibril diameter provides greater elastic properties, which is of
consistence to the region-specific function of patellar tendon. So
Figure 5. Effects of siRNA treatment on the extracellular matrix (ECM) deposition and collagen fibril diameter. The influence of siRNA
treatment on relative collagen deposition (A) and relative mean diameter (B) (* P,0.05 compared with negative control group, n=3). The influence of siRNA
silencing on the expression of some ECMgenes andtheir proportions tocollagentype Iin tissue engineeredtendon(C: Col1a1; D: Col3 a1; E: Decorin; F: Col5
a1/ Col1 a1; G: Col5 a2/Col1 a1; H: Col3 a1/Col1 a1; I: Decorin/Col1 a1), (*P,0.05, **P,0.01, ***P,0.001 compared with normal tendon group, n=3).
doi:10.1371/journal.pone.0021154.g005
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both small and large diameter fibrils [27,28]. However, during the
process of repair, collagen fiber diameter is notably smaller compared
to the normal health one and the larger fiber in the health tendon
occupy the most volume, so now for tendon repair, regeneration of
larger diameter is one of the major challenge.
Figure 6. Transmission electron microscopic analysis and histogram of collagen fiber diameters of tissue engineered tendons
formed by coculture of Col5a1 siRNA treated tenocytes and normal tenocytes at different ratios [A, 1:0; B, 1:0.5; C, 1:1; D, 1:2; E, 1:3;
F, 0:1 (NC), magnification 730006]. (G) The relative mean diameters of tissue engineered tendons formed by cocultured cells at different ratios
(* P,0.05 compared with negative control group, n=3).
doi:10.1371/journal.pone.0021154.g006
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of tendon
Previous studies of tendon biology used either in vitro cell
cultures or animal models [21,22], but both of them have several
inherent disadvantages. In our study, a relative well-organized
collagen fibrils resembling tendon ultrastructure is formed. Mean-
while, the tissue engineered tendon is scaffold-free, so there are
fewer exogenous factors. It can be easily and efficiently used to
evaluate the role of gene intervention (e.g. RNAi and antisense
techniques) in tendon research. In addition, our tissue engineered
tendon is an excellent setup to simulate injured tendon. It has a
uniform distribution of small diameter collagen fibrils along with a
high level of type V collagen expression, which is characteristic of
injured tendon [6,19]. Although the tissue engineered tendon lacks
a fair bit in the mechanical perspective and has less efficient
fibrillogenesis, it still illustrates a novel model and strategy for
future tendon biology research and studies.
Effects of different chains of collagen V on tendon
fibrillogenesis
This study assessed the function of two chains of collagen V.
The amount of collagen deposited in the tissue engineered tendon
indicated that down-regulated collagen V impaired collagen
formation in Achilles tenocytes. The down-regulation of Col I
expression and consequently possible affected Col I turnover may
be one of the reasons that contributed to the collagen deposition
decrease. Moreover, it seems that the influence of Col5a1o nf i b r i l
formation was more apparent than that of Col5a2. Tissue engi-
neered tendon treated with Col5a1 siRNA had abnormal col-
lagen fibril morphology while tendon treated with Col5a2s i R N A
had collagen fibrils similar to controls. Published data indicate
that cells deficient in Col5a1 would be null for type V collagen
since all three isoforms contain this chain, while cell deficient in
Col5a2 would be expected to assemble the a1(V)3 homotrimer.
However, unlike the heterotrimer a1(V)2a2(V), the homotrimer
a1(V)3 was shown to not assemble into heterotypic type I/V fibrils
and hence did not participate in collagen fibrils formation [18].
So, the difference of collagen fibrillogenesis between Col5a1and
Col5a2 siRNA treatments may be caused by the over-depression
of Col5a1. Real time PCR results indicated that Col5a1s i R N A
and Col5a2 siRNA had different effects on the expression of
Col1a1 and decorin at the mRNA level. Col5a1s i R N A
decreased the ratios of Col5a1, Col3a1a n dd e c o r i nt oC o l 1 a1,
whereas Col5a2 siRNA increased the ratios of Col5a1, Col3a1
and decorin to Col1a1. Collagen type I is the major quantitative
component in collagen fibrils, whereas Col5a1a n dC o l 3 a1a r e
two minor quantitative contents. The ratios between these two
genes and Col1a1 are reversely related to the fibril diameter [29–
33]. Thus, it is a paradox since all the ratio values were decreased
while the fibrils diameter is also smaller in the Col5a1s i R N A
group. Over silencing of Col5a1 may be the answer for such
contradiction. The sharp reduction of collagen V and decorin by
Col5a1 siRNA may could not assemble enough a1(V)2a2(V)
functional isoform and proteoglycan to form V/I heterotypic
fibrils and collagen-proteoglycan heteropolymers to fulfill the
minimal requirement of collagen I fibril formation [23]. In the
Col5a2 siRNA-treated group, those ratios are consisted with the
diameters. Decorin belongs to small leucine-rich proteoglycans/
proteins (SLRPs) and the formation of collagen-proteoglycan
heteropolymers is important in regulation of fibrillogenesis [34–
37]. Whether the ratios of decorin to collagen type I may also be
inversely proportional to collagen fibril diameter is needed to be
determined.
Collagen formation processes are driven by the loss of solvent
molecules in cell-surface crypts [38] and result in assemblies with a
circular cross-section. Type V and type I collagen co-assemble into
heterotypic fibrils and regulate the initial fibril assembly. This
assembly is completely processed outside the cell [39]. Over-
depression of collagen V in tissue engineered tendon using Col5a1
siRNA maybe caused small and abnormal collagen fibrils, so we
cocultured Col5a1 siRNA treated tenocytes and normal tenocytes
with different ratios. The coculture experimental results revealed
that collagen fibrils of cocultured groups with a ratio of 1:0.5 or 1:1
had similar morphology and larger diameters, while collagen
fibrils of cocultured groups with a ratio of 1:0, 1:2 or 1:3 were
smaller. These results indicated that there was an optimal level of
collagen type V and the level was vital in regulating collagen
fibrillogenesis. The undetermined precise level of collagen type V
is the limitation of the present study and warrants further in-
vestigation to obtain. Although the mechanisms involved need
further investigation, and the effects of both chains blocked should
be studied, these findings provided useful information for the
development of molecular biology- and cell-based therapeutics for
improving injured tendon repair in future.
Effect of different chains of collagen V on cell
proliferation and apoptosis
Our results in siRNA treated tendon cells suggest collagen V
involvement in biological processes besides fibrillogenesis. A few
more Col5a2 siRNA-treated cells were DAPI positive and exhi-
bited morphological signs of apoptosis, as judged by fluorescence
microscopy, while Col5a1 siRNA had a modest negative influence
on cell growth and apoptosis. The apoptosis of Col5a2 siRNA-
treated cells may be a consequence of the loss of important cell-
matrix interactions.This finding isinline with the establishedrole of
the extracellular matrix in sustaining cell survival. Changes in
matrix composition may affect the adhesion signals of cells [26] and
the storage and activation of growth factors [40]. Previous studies
using mice harboring a targeted deletion of the Col5a2 gene have
shown increased apoptosis of stromal fibroblasts in skin [26].
RNAi for tendon matrix gene regulation
This study showed that siRNA interference successfully inhi-
bited procollagen a1 and a2 (V) synthesis in rat Achilles tendon
fibroblasts. RNAi is the process of sequence specific, post-tran-
scriptional gene silencing directed by short interfering 21–23 nt
double-stranded RNA (siRNA) [41]. siRNAs act as guides to acti-
vate the RNA-induced silencing complex, which cleaves homol-
ogous mRNA molecules [25]. Many studies have demonstrated
that the introduction of siRNAs into mammalian and human cells
causes specific and effective suppression of the corresponding
mRNAmolecules [25,41–43]. Severallinesof evidence that siRNAs
inhibit the in vivo expression of endogenous genes provides further
support forthenotionthat specificsiRNAs maybea newalternative
to gene-specific therapeutics of human diseases [43]. For the
therapeutic application of siRNA technology, it is critical to employ
an efficient gene delivery system for transduction of siRNA into
target cells.
In conclusion, analysis of the different chains of collagen type V
shed light on the role of this minor collagen type in fibrillogenesis
and tendon regeneration. Our experiments document the critical
contribution of the a1 (V) and a2 (V) chains to fibrillogenesis, fibril
organization, and cell viability. In addition, this work successfully
used scaffold-free tendon tissue engineered model to mimic tissue
in vivo for investigating the biological process of collagen fibril-
logenesis. This provides a simple and controllable model for future
Col V siRNA Engineered Tendon
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in injured tendon repair is vital and its details need further
investigation.
Materials and Methods
Cell culture
Primary tenocytes were isolated from the Achilles tendon of
Sprague-Dawley rats. The Protocols were approved by the animal
care and use committee of Zhejiang University. The ethical grant
number is zju2007102001. In brief, Achilles tendons were har-
vested and adjacent tissues were stripped. After soaking in phos-
phate-buffered saline (PBS) containing penicillin (100 units/ml)
and streptomycin (100 mg/ml) (Gibco, Carlsbad, CA, USA) for
10 min, the tendon was cut into small fragments followed by
enzyme digestion with a 0.2% (W/V) collagenase mixture (Gibco,
Carlsbad, CA, USA) at 37uC in a humidified atmosphere of 5%
CO2 and 95% air. After 4 h, an equal volume of Dulbecco’s
modified Eagle medium (DMEM) containing 10% (V/V) fetal
bovine serum (FBS; Gibco, Carlsbad, CA, USA) was added and
the mixture digested overnight. Next day, the tissue residue was
removed and the resulting cell suspension was centrifuged at
1,200 rpm. The harvested cells were maintained in DMEM con-
taining 10% (V/V) FBS with medium changed every 2–3 days.
When cultured primary cells reached 80% confluence, they were
detached by treatment with 0.25% (W/V) trypsin and 0.1%
ethylenediaminetetraacetic acid (Gibco, Carlsbad, CA, USA) and
subcultured at a density of 1 6 10
4/cm
2. Cultured cells before
passage 5 were used for experiments.
siRNA synthesis and transfection
Two target sequences (Table 1) for mRNAs of the a1 and a2
chains in rat collagen type V were chosen according to the online
Ambion siRNA design tool. The specificity of all sequences was
confirmed by BLAST search. All siRNAs were synthesized by
Ambion Co. (Austin, TX, USA). The positive control (PC, targeting
the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase,
GAPDH siRNA) and FAM-labeled negative control (NC, scram-
bled siRNA) siRNAs were from Ambion. Transfection of siRNA
was performed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s protocol.
Quantitative reverse transcription-polymerase chain
reaction (qRT-PCR)
In this study, the gene expressions of the a1 type I collagen gene
(Col1a1), the a1 type III collagen gene (Col3a1) , Col5a1 and
Col5a2 of injured tendon tissue, normal tendon tissue and tissue
engineered tendon were detected. The injured tendon tissue was
removed from the Achilles tendon of Sprague-Dawley rats, which
had suffered a gap wound model (1 mm in width and 4 mm in
length) and was repaired with no treatment after one week [44].
The normal tendon tissue was removed from the Achilles tendon
of Sprague-Dawley rats.
In the siRNAs treated experiment, tenocytes were cultured for
48 h after transfection. Real-time PCR was used to detect the
mRNAs encoding Col5a1, Col5a2, Col1a1, Col3a1, decorin and
GAPDH (n=3). Total cellular RNA was isolated by lysis in Trizol
(Invitrogen, Carlsbad, CA, USA) followed by one-step phenol
chloroform-isopropyl alcohol extraction as described in the
protocol. For real-time PCR, 2 mg of total RNA from each sample
was reversed transcribed using mMLV reverse transcriptase
(Invitrogen, Carlsbad, CA, USA). 1/1000 of the reverse tran-
scription reaction was used for subsequent qRT-PCRs, which were
set up using TaKaRa Universal PCR Master Mix on an ABI 7900
HT Real-Time PCR System (Applied Biosystems). Target genes
were normalized against the housekeeping gene b-actin. Specific
primers are shown in Table 2.
Immunofluorescence staining and quantitative analysis
Immunofluorescence staining was used to detect procollagen
type V a1 and a2 chains expression in protein level after treated
with specific siRNAs. Tenocytes were grown on the bottom of
plastic dishes containing growth medium, and were treated with
specific siRNAs. After 48 h, cells were fixed in 4% paraformal-
dehyde in PBS (pH 7.4) for 15 minutes and then immersed in
blocking solution containing 1% bovine serum albumin and 0.3%
Triton X-100 for 1 h at room temperature. After washing 3 times
in PBS, cells were incubated overnight at 4uC with rabbit and goat
polyclonal antibodies against Col5a1 and Col5a2 respectively
(1:100, Santa Cruz, USA), followed by incubation with fluores-
cence isothiocyanate-conjugated (green,1:200, Beyotime, China)
and cyanine 3-conjugated (red, 1:30, Sigma, USA) secondary
antibody for 1 h. Cells treated with transfection agent only were
used as control group. Finally, the incubated cells were rinsed in
PBS and observed under a microscope (Olympus, Tokyo, Japan)
(n=3). After immunofluorescence experiment, three pictures of
separate view fields were chosen randomly for each sample, and
then Image-Pro Plus 5.1.2 was used to quantify the expression
level of each procollagen by calculating the related color density.
MTT assay
Cell survival was determined by MTT assay 1 day and 3 days
after treatment of Col5a1 and Col5a2 siRNAs (n=3). This
measure was based on the cleavage of MTT into a blue-colored
product (formazan) by the mitochondrial enzyme succinate
dehydrogenase [45–47]. MTT (50 mg/ml) was added and
incubated at 37uC for 4 h. Then, the MTT solution was discarded
and 150 mL of dimethyl sulfoxide was added to dissolve the
formazan crystals. The plates were then fully shaken to dissolve the
formazan crystals formed. The optical density was measured at
Table 1. siRNA sequences of Col5a1 and Col5a2.
Si RNA ID Target Chain Oligonucleotide Sequence (59-39)
196226 a1 GCAGCUGUACCCUGAGUCUtt
196227 a1 CGAUGAGGAAAUGUCUUAUtt
s136861 a2 GUCUCUCAGUAGUCAAAUUtt
s136862 a2 CACUGUUGGUUAUAUGGAUtt
doi:10.1371/journal.pone.0021154.t001
Table 2. Specific primers used for real-time PCR.
Gene Sense (59-39) Antisense (59-39)
Col5a1 GGACTCGGCGGAACATT GGAGTTGAGGGAACCAAAGAT
Col5a2 TGTGCGGGGAAGTGTAG CCAAGAGCAGCAGTAAGAT
Col1a1 TGGATGGCTGCACGAGT TTGGGATGGAGGGAGTTTA
Col3a1 GCCTCCCAGAACATTACATA CAATGTCATAGGGTGCGATA
Decorin ACCACAGTCCATGCCATCAC AGACTCACGGCAGTGTAGGA
Gapdh GCAAGTTCAACGGCACAG CGCCAGTAGACTCCACGAC
b-Actin AAGATGACGCAGATCATGTTGAG AGGAGGAGCAATGATCTTGATCTT
doi:10.1371/journal.pone.0021154.t002
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tems, Waltham, MA, USA).
Cell morphological assessment and DAPI staining
To detect morphological evidence of apoptosis, cell nuclei were
visualized after DNA staining with the fluorescent dye DAPI.
Briefly, cells were seeded on coverslips in 24-well tissue culture
plates and treated with specific siRNA oligonucleotides. After 3
days, the morphology of cells was monitored under an inverted
light microscope. Cells were fixed with 4% paraformaldehyde for
20 min, washed with PBS, and then incubated with DAPI (1 mg/
mL) for 10 min. After washing with PBS, cells were observed using
fluorescent microscopy (Olympus, Tokyo, Japan) at a peak
excitation wavelength of 340 nm (n=3).
Fabrication of the tissue engineered tendon
To conveniently detect the collagen fibril synthesis in in vitro
study, a scaffold-free tissue engineered tendon was developed with
tendon cell sheets. Tenocytes were cultured in high glucose
DMEM with 10% (v/v) FBS. To prevent cell senescence and
promote extracellular matrix synthesis 50 mg/mL of ascorbic acid
was added to the medium. Cells proliferated rapidly and formed
coherent cellular sheets within 2 weeks. The cell sheets could be
detached from the substratum by applying a small roll-up force
[24]. The cell sheets were called tissue engineered tendon and used
for gene expression andcollagen content detection , as well as tran-
smission electron microscopy analysis in subsequent experiments.
Histological examination and Masson trichrome staining
To validate whether the tissue engineered tendon mimics tissue
in vivo, the morphology property of tissue engineered tendon was
detected. The engineered tendon without siRNA treatment was
fixed in 10% neutral buffered formalin, dehydrated through an
alcohol gradient, cleared, and embedded in paraffin. Histological
sections (10 mm) were prepared using a microtome and subse-
quently stained with hematoxylin-eosin and Masson trichrome
according to standard procedures to examine the general
appearance of the collagen fibrils [48,49] (n=3).
Determination of collagen content of cell sheet
For collagen synthesis studies, cells were transfected with specific
siRNA oligonucleotide every four days until a cell sheet was
formed. The cells were washed with PBS three times. The amount
of deposited collagen in the cell sheet was quantified using a
collagen assay kit and following the manufacturer’s protocol,
which was a colorimetric-based hydroxyproline assay used to
estimate total collagen content and concentration(n=3, Jiancheng
Ltd., Nanjing, China) [48]. The content was measured using the
Multiskan Spectrum ELIASA at 550 nm.
Transmission electron microscopic analysis
To verify that extracellular matrix deposited in the tissue
engineered tendon, transmission electron microscopy (TEM) was
used to assess the diameter of the collagen fibrils and fibril align-
ment. Briefly, samples were prefixed with 2.5% glutaraldehyde for
2 h at 4uC and washed twice with PBS at 4uC followed by
postfixation with 1% osmic acid for 2 h at 4uC. After two washes
in PBS, the samples were dehydrated in an ethanol gradient and
dried to a critical point. Then the samples were mounted and
sputter-coated with gold for viewing in a TEM (Quanta 10 FEI)[50].
About 500 collagen fibrils were measured in each sample to obtain
a true representation of the fibril diameter distribution (n=3).
Ratio coculture experiments
To find an optimal level of collagen type V in regulating
collagen fibrillogenesis, we duplicated the experiment of cocultur-
ing Col5a1 siRNA treated tenocytes with normal tenocytes in
different ratios. The tenocytes were treated with Col5a1 siRNA
three times every 4 days and then detached using 0.25% trypsin
and 0.1% ethylenediaminetetraacetic acid (EDTA). Finally, those
treated tenocytes were cocultured with untreated tenocytes in a
ratio of 1:0, 1:0.5, 1:1, 1: 2 or 1:3. Also, we cultured a control
group of normal tenocytes. After two weeks, cell sheets were
formed and the TEM analysis was detected (n=3).
Statistical analysis
The results are presented as mean 6 standard deviation of the 3
samples from each group. The significance of differences was
analyzed by Q-test of one-way ANOVA and p ,0.05 was
considered as statistically significant.
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